2017-2021 Cancer Diagnostics Market: Sales Forecasts by Country, Strategic Profiles of Leading Suppliers, Emerging Tests, Innovative Technologies, Instrumentation Review

February 2017 | 510 pages | ID: CD393BA1290EN
Venture Planning Group

Abstracts

This new report from VPGMarketResearch.com provides analysis of the global cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents:

• Estimated numbers of cancer testing laboratories, as well as test volume and sales forecasts for France, Germany, Italy, Japan, Spain, U.K. and U.S.
• Marketing and technological assessment, as well as medical rationale and diagnostic prospects for major categories of circulating and cellular tests, such as Biochemical Markers, Oncogenes, Growth Factors, Hormones, Colony Stimulating Factors, Lymphokines, Immunohistochemical Stains and others.
• Overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as listings of companies, universities and research centers developing or marketing new technologies, products, and applications.
• Review of current instrumentation used for cancer diagnostic testing.
• Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing.
• Competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy.
• Profiles of current and emerging suppliers of cancer diagnostic products, including their sales, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies.

Contains 510 pages and 31 tables

Contents

I. Worldwide Business Environment
II. Worldwide Market Structure
III. Major Current And Emerging Cancer Diagnostic Tests
  1. INTRODUCTION
  2. TUMOR MARKER CLASSIFICATION
  3. ACTH
  4. ALPHAFETOPROTEIN (AFP)
  5. BETA2 MICROGLOBULIN
  6. CA 153/27.29
  7. CA 199
  8. CA125
  9. CALCITONIN
  10. CARCINOEMBRIONIC ANTIGEN (CEA)
  11. ESTROGEN AND PROGESTERONE RECEPTORS
  12. FERRITIN
  13. GASTRIN
  14. HUMAN CHORIONIC GONADOTROPIN (HCG)
  15. INSULIN
  16. NSE
  17. OCCULT BLOOD
  18. PAP SMEAR/HPV
  19. PROSTATIC ACID PHOSPHATASE (PAP)
  20. PROSTATESPECIFIC ANTIGEN (PSA)
  21. SQUAMOUS CELL CARCINOMA ANTIGEN (SCC)
  22. T AND B LYMPHOCYTES
  23. TDT
  24. THYROGLOBULIN
  25. TISSUE POLYPEPTIDE ANTIGEN (TPA)
  26. BIOCHEMICAL TUMOR MARKERS
ADA

BProtein
PNP

5'Nucleotidase
  27. ONCOGENES
Abl/ablbcr
AIB1
BCL2
BRCA1
CD44

Cfos
Cmyb
Cmyc
CYP17

ErbB
HPC1

Nmyc
P40
P51
P53
PIK3CA
PTI1

Ras
Reg
Sis
Src
  28. POLYPEPTIDE GROWTH FACTORS
Basic Fibroblast Growth Factor
BetaTGF
Cachectin (TNT)
Calmodulin
ECFR

Nerve Growth Factor (NGF)
Epidermal Growth Factor (EGF)
Ornithine Decarboxylase
Transferrin
Transforming Growth FactorAlpha
  29. ECTOPIC HORMONES
  30. COLONY STIMULATING FACTORS
  31. LYMPHOKINES
AlphaInterferon
B Cell Growth Factors
B Cell Growth Factor (BCGF)
GammaInterferon
Interleukin1 (IL1)
Macrophage Activating Factor
  32. IMMUNOHISTOCHEMICAL STAINS
  33. EMERGING TUMOR MARKERS
NAcetylglucosamine
Actin
AlphaActin
Antineuronal Antibodies
7B2
B72.3

Bax
BCDF9
BLCA4

Blood Group Antigens A,B,H
CA
CA 724/TAG72
CA
CA242
CA549
CAM
CAR3

CathepsinD
Chromogranin A and B
Cluster 1 Antigen
Cluster5/5A Antigen
CTA
CU18
DR70
DUPAN2

Endometrial Bleeding Associated Factor
Endostatin
Epithelial Membrane Antigen
Feulgen Hydrolysis
Fibronectin
FSH

(1>3)Lfucosyltransferase
GastrinReleasing Peptide (GRP)
GDCFP15

Glucagon
Glycoamines
H23

Her2
Human Carcinoma Antigen
HPA
HSP27

Intermediate Filaments
Cytokeratins/CK18/Cyfra 211
Desmin
Gliofibrillary Acid Protein
Neurofilaments
Vimentin
KA

Kinases
KP16D3
LAI

Leukocyte Common Antigen
Lewis Antigens
Lysophosphatidic Acid (LPA)
Ma 695/Ma
MABDF3
MAG
ME1

Minactivin
MN/CA9
MSA

Mucin Cancer Antigen (MCA)
Multiple Tumor Suppressor
Myosin
NEA130
NMP22
OA519

Opiod Peptides
Pglycoprotein
Pancreatic Oncofetal Antigen (POA)
Placental Lactogen
PR92

Proliferative Index, Ki67
Px
RB Inactivation/Deletion
Ret
SCCL

Selectin
Sialic Acid
Sialyl SSEA1/SLX
SN10

Somatostatin
TA90
TABA

Tachykinin
TAG
TPS

Troponin
Tubulin
VCAM
VEGF

Villen
IV. Instrumentation Review: Leading Analyzers Marketed by Abbott, Beckman Coulter/Danaher, Binding Site, bioMerieux, Carolina Chemistries, DiaSorin, Horiba, Inverness/Alere, J&J, Olympus, Roche, Siemens, Tosoh, Vital Diagnostics and other suppliers
V. Current and Emerging Technologies
  1. MONOCLONAL AND POLYCLONAL ANTIBODIES
  2. IMMUNOASSAYS
    a. Technological Principle
    b. Radioimmunoassay (RIA)
    c. Enzyme Immunoassays (EIA)
Overview
ELISA
Immunofiltration
ParticleMembrane Capture Immunoassay
Enzyme Amplification
    d. Fluorescent Immunoassays
    e. Luminescence
Chemiluminescence
Bioluminescence
    f. Latex Agglutination
    g. Immunoprecipitation
H. Affinity Chromatographu
    e. Liposome FlowInjection Immunoassay
  3. MOLECULAR DIAGNOSTICS
    a. Technology Overview
    b. Amplification Methods
PCR
DAPPCR

ImmunoPCR
QCPCR
CAR
DNA
HPA
LCR
NASBA
QBR
SDA

3 SR, and others
  4. CHROMOSOME ANALYSIS
    a. Chronic Myelogenous Leukemia (CML)
    b. Acute Myeloid Leukemia (AML)
    c. Acute Lymphoblastic Leukemia (ALL)
    d. Malignant Lymphomas Lymphoid Malignancies
    e. Chronic Lymphocytic Leukemia (CLL)
    f. Solid Cancers
    g. Chromosomal Translocation and Oncogenes
  5. ARTIFICIAL INTELLIGENCE
  6. FLOW CYTOMETRY
  7. TW      DIMENSIONAL GEL ELECTROPHORESIS (2DGE)
  8. BIOSENSORS
  9. COMPETING/COMPLEMENTING TECHNOLOGIES
    a. CT
    b. MRI
    c. NMR
    d. PET
    e. Photonics Spectroscopy

VI. COMPETITIVE PROFILES

Abbott
AdnaGen
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biomedical Diagnostics
bioMerieux
BioRad
CellSearch
Cepheid
Decode Genetics
Diadexus
Diagnocure
Diasorin
Eiken Chemical
Elitech Group
Enterix
Enzo Biochem
Epigenomics
Exact Sciences
Fujirebio
Hologic/GenProbe
Guided Therapeutics
Kreatech/Leica
Kyowa Medex
Mackay Life Sciences
Myriad Genetics
OncoLab
OrthoClinical Diagnostics
Panacea Pharmaceuticals
Polartechnics
Polymedco
PreMD
Qiagen/Ipsogen
Radient Pharmaceuticals
Roche
Scienion
Sequenom
Siemens Healthcare
Takara Bio
Targeted Diagnostics & Therapeutics
Tosoh
Thermo Fisher
Vermillion/Correlogic Systems
Wako Pure Chemicals
Wallac/PE
Zila
Appendixes: Major Universities and Research Centers Developing
Cancer Diagnostic Technologies and Applications

List Of Tables

LIST OF TABLES

Tumor Marker Classification
Major Companies Developing or Marketing ACTH Tests
Major Companies Developing or Marketing AFP Tests
Major Companies Developing or Marketing Beta2 Microglobulin Tests
Major Companies Developing or Marketing CA 153/27.29 Tests
Major Companies Developing or Marketing CA 199 Tests
Major Companies Developing or Marketing CA 125 Tests
Major Companies Developing or Marketing Calcitonin Tests
Major Companies Developing or Marketing CEA Tests
Major Companies Developing or Marketing Estrogen Receptor Tests
Major Companies Developing or Marketing Progesterone Receptor Tests
Major Companies Developing or Marketing Ferritin Tests
Major Companies Developing or Marketing Gastrin Tests
Major Companies Developing or Marketing HCG Tests
Major Companies Developing or Marketing Insulin Tests
Major Companies Developing or Marketing NSE Tests
Major Companies Developing or Marketing Occult Blood Tests
Major Companies Developing or Marketing PAP Smear/HPV Tests
Major Companies Developing or Marketing PAP Tests
Major Companies Developing or Marketing PSA Tests
Major Companies Developing or Marketing Lymphocyte Subclassification Tests
Biochemical Markers Potential Applications
In Cancer Diagnosis
Oncogenes Potential Applications
In Cancer Diagnosis
Major Companies Developing or Marketing Oncogene Tests
Growth Factors Potential Applications
In Cancer Diagnosis
Colony Stimulating Factors Potential
Applications in Cancer Diagnosis
Lymphokines Potential Applications
In Cancer Diagnosis
Immunohistochemical Stains Potential
Applications in Cancer Diagnosis
Worldwide, All Market Segments, Laboratories Performing Cancer Diagnostic Testing By Country
Worldwide, All Market Segments, Cancer Diagnostic Test Volume Forecasts By Country
Worldwide, All Market Segments, Cancer Diagnostics Sales Forecasts By Country